LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 36.01 27.76 1421 2662 0.5336 0.8180
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 36.01 27.76 190 2662 0.0714 0.3393
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 36.01 27.76 1971 2662 0.7402 0.9107
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 37.71 27.76 73 2877 0.0254 0.1554
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 37.71 27.76 1662 2877 0.5776 0.8426
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 37.71 27.76 1481 2877 0.5147 0.8111
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 37.71 27.76 1512 2877 0.5254 0.8167
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 37.71 27.76 217 2877 0.0754 0.3595
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 37.71 27.76 2015 2877 0.7002 0.8963
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 39.41 27.76 93 3105 0.0299 0.1944
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 39.41 27.76 1710 3105 0.5506 0.8321
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 39.41 27.76 1390 3105 0.4476 0.7772
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 39.41 27.76 1421 3105 0.4576 0.7829
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 39.41 27.76 238 3105 0.0766 0.3712
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 39.41 27.76 2082 3105 0.6704 0.8859
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 41.11 27.76 86 3331 0.0258 0.1779
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 41.11 27.76 1820 3331 0.5463 0.8324
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 41.11 27.76 1518 3331 0.4557 0.7849
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 41.11 27.76 1567 3331 0.4704 0.7931
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 41.11 27.76 254 3331 0.0762 0.3778
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 41.11 27.76 2269 3331 0.6811 0.8918
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 42.81 27.76 101 3596 0.0281 0.2021
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 42.81 27.76 1906 3596 0.5300 0.8270
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 42.81 27.76 1691 3596 0.4702 0.7961
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 42.81 27.76 1763 3596 0.4902 0.8068
MN20160318_Q01
H05